Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

JM 118

Known as: JM-118, JM118 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
IntroductionChemotherapy for advanced well-differentiated carcinoids is characterised by low response rates and short duration of… Expand
Is this relevant?
2010
2010
PURPOSE Dichloroacetate (DCA) inhibits pyruvate dehydrogenase kinase (PDK), and thus promotes glucose oxidation over glycolysis… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2008
2008
1. Satraplatin is an investigational orally administered platinum-based antitumour drug. The present study compared the plasma… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2007
2007
PurposeSatraplatin is an orally available platinum analog. The purpose of this study was to better characterize satraplatin’s… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2005
2005
Background. Satraplatin is thought to require reduction to a reactive Pt(II) complex (JM118) before exerting chemotherapeutic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
The hydrolysis process of the anticancer drug cis-amminedichlorocyclohexylamineplatinum(II) (JM118 or cis-[PtCl2(NH3… Expand
Is this relevant?
2002
2002
HeadingAbstractPurpose. Satraplatin is an orally administered platinum complex that has demonstrated clinical activity and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1999
1999
The cellular pharmacology of two pairs of cis and trans platinum complexes has been studied in three human ovarian carcinoma cell… Expand
Is this relevant?
1996
1996
Abstract This study evaluates the metabolic profile of JM216 [bis(acetato)ammine-dichloro(cyclohexylamine) platinum(IV)], the… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1995
1995
The mechanisms by which cis-diamminedichloroplatinum(II) (cisplatin) is transported across the plasma membrane (i.e., passive… Expand
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • figure 4
Is this relevant?